Steward Partners Investment Advisory, LLC Editas Medicine, Inc. Transaction History

Steward Partners Investment Advisory, LLC

$10.6 Billion
Q3 2024

A detailed history of Steward Partners Investment Advisory, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 425 shares of EDIT stock, worth $514. This represents 0.0% of its overall portfolio holdings.

Number of Shares

425

Previous 745 42.95%

Holding current value

$514

Previous $3,000 66.67%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.39 - $5.96 $1,084 - $1,907	-320 Reduced 42.95%	425 $1,000
Q2 2024 Aug 08, 2024	BUY	$4.67 - $7.28 $294 - $458	63 Added 9.24%	745 $3,000
Q1 2024 May 15, 2024	BUY	$7.03 - $11.07 $611 - $963	87 Added 14.62%	682 $5,000
Q4 2023 Feb 12, 2024	SELL	$6.25 - $11.11 $293 - $522	-47 Reduced 7.32%	595 $6,000
Q3 2023 Nov 13, 2023	SELL	$6.92 - $9.31 $1,349 - $1,815	-195 Reduced 23.3%	642 $5,000
Q2 2023 Aug 14, 2023	SELL	$6.36 - $11.47 $3,879 - $6,996	-610 Reduced 42.16%	837 $6,000
Q1 2023 May 15, 2023	BUY	$7.03 - $11.53 $3,529 - $5,788	502 Added 53.12%	1,447 $10,000
Q4 2022 Feb 15, 2023	BUY	$8.32 - $13.21 $665 - $1,056	80 Added 9.25%	945 $8,000
Q3 2022 Nov 10, 2022	BUY	$12.16 - $19.42 $912 - $1,456	75 Added 9.49%	865 $11,000
Q2 2022 Aug 04, 2022	SELL	$9.99 - $21.35 $5,004 - $10,696	-501 Reduced 38.81%	790 $9,000
Q1 2022 May 02, 2022	SELL	$14.08 - $27.63 $3,055 - $5,995	-217 Reduced 14.39%	1,291 $25,000
Q4 2021 Feb 08, 2022	SELL	$26.55 - $40.57 $71,419 - $109,133	-2,690 Reduced 64.08%	1,508 $40,000
Q3 2021 Nov 12, 2021	BUY	$39.27 - $72.94 $79,286 - $147,265	2,019 Added 92.66%	4,198 $172,000
Q2 2021 Aug 13, 2021	SELL	$31.29 - $56.64 $14,080 - $25,488	-450 Reduced 17.12%	2,179 $123,000
Q1 2021 May 14, 2021	BUY	$39.71 - $90.58 $76,124 - $173,641	1,917 Added 269.24%	2,629 $110,000
Q4 2020 Feb 11, 2021	BUY	$27.07 - $84.35 $15,700 - $48,923	580 Added 439.39%	712 $50,000
Q3 2020 Oct 30, 2020	BUY	$28.06 - $37.16 $2,385 - $3,158	85 Added 180.85%	132 $4,000
Q2 2020 Aug 06, 2020	BUY	$18.5 - $34.34 $869 - $1,613	47 New	47 $1,000
Q1 2020 Apr 29, 2020	SELL	$14.88 - $32.78 $11,904 - $26,224	-800 Closed	0 $0
Q4 2019 Jan 17, 2020	SELL	$19.49 - $32.63 $15,591 - $26,104	-800 Reduced 50.0%	800 $23,000
Q3 2019 Oct 30, 2019	BUY	$22.49 - $26.81 $11,245 - $13,405	500 Added 45.45%	1,600 $36,000
Q2 2019 Jul 25, 2019	BUY	$20.48 - $27.76 $22,528 - $30,536	1,100 New	1,100 $27,000
Q4 2018 Jan 15, 2019	SELL	$18.19 - $31.79 $20,918 - $36,558	-1,150 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$27.65 - $38.39 $12,442 - $17,275	450 Added 64.29%	1,150 $37,000
Q2 2018 Jul 20, 2018	BUY	$31.4 - $41.01 $4,710 - $6,151	150 Added 27.27%	700 $25,000
Q1 2018 Apr 20, 2018	SELL	$29.84 - $44.08 $746 - $1,102	-25 Reduced 4.35%	550 $18,000
Q4 2017 Jan 19, 2018	BUY	$21.89 - $31.34 $8,208 - $11,752	375 Added 187.5%	575 $17,000
Q4 2016 Nov 22, 2017	BUY	N/A	200	200 $3,000

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $83.2M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account

Steward Partners Investment Advisory, LLC Editas Medicine, Inc. Transaction History